IL98932A0 - Assay,kits and methods based on nk+channel expression - Google Patents

Assay,kits and methods based on nk+channel expression

Info

Publication number
IL98932A0
IL98932A0 IL98932A IL9893291A IL98932A0 IL 98932 A0 IL98932 A0 IL 98932A0 IL 98932 A IL98932 A IL 98932A IL 9893291 A IL9893291 A IL 9893291A IL 98932 A0 IL98932 A0 IL 98932A0
Authority
IL
Israel
Prior art keywords
kits
assay
methods based
channel expression
expression
Prior art date
Application number
IL98932A
Other languages
English (en)
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of IL98932A0 publication Critical patent/IL98932A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL98932A 1990-07-27 1991-07-23 Assay,kits and methods based on nk+channel expression IL98932A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55856890A 1990-07-27 1990-07-27

Publications (1)

Publication Number Publication Date
IL98932A0 true IL98932A0 (en) 1992-07-15

Family

ID=24230051

Family Applications (1)

Application Number Title Priority Date Filing Date
IL98932A IL98932A0 (en) 1990-07-27 1991-07-23 Assay,kits and methods based on nk+channel expression

Country Status (10)

Country Link
US (1) US5827655A (ja)
EP (1) EP0541704A4 (ja)
JP (1) JPH06500017A (ja)
AU (1) AU652381B2 (ja)
CA (1) CA2087268A1 (ja)
FI (1) FI930178A0 (ja)
IE (1) IE912645A1 (ja)
IL (1) IL98932A0 (ja)
PT (1) PT98468B (ja)
WO (1) WO1992002634A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993022422A1 (en) * 1992-04-27 1993-11-11 Northwestern University Genetically engineered eukaryotic organism capable of detecting the expression of heterologous ion channels
WO1994019464A2 (en) * 1993-02-19 1994-09-01 The Upjohn Company Human dna sequence encoding a kidney atp-dependent potassium channel
US5637470A (en) * 1994-05-13 1997-06-10 Merck & Co., Inc. Screening array using cells expressing recombinant α and β subunits of the mammalian large-conductance (maxi-K) potassium channel
US5710019A (en) * 1995-06-05 1998-01-20 Human Genome Sciences, Inc. Human potassium channel 1 and 2 proteins
US5831055A (en) * 1995-09-15 1998-11-03 Pharmacia & Upjohn Company DNA encoding a novel kidney ATP-dependent potassium channels
US6979547B2 (en) * 1998-03-25 2005-12-27 Cornell Research Foundation, Inc. Methods for designing specific ion channel blockers
DE19920044A1 (de) * 1999-04-23 2000-10-26 Forschungsgesellschaft Genion Expression bakterieller Kaliumkanäle in eukaryontischen Wirtszellen und deren Verwendung zur Identifizierung von Antibiotika
US20030211575A1 (en) * 2001-02-07 2003-11-13 Swartz Kenton J. Constituitively open voltage-gated kand methods for discovering modulators thereof
DE10243599A1 (de) * 2002-09-19 2004-04-01 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Messvorrichtung und -verfahren für ein Screening bei auf Elektroden immobilisierten Zellen
US7833979B2 (en) 2005-04-22 2010-11-16 Amgen Inc. Toxin peptide therapeutic agents
US7820623B2 (en) 2006-10-25 2010-10-26 Amgen Inc. Conjugated toxin peptide therapeutic agents
JP5591691B2 (ja) 2007-05-22 2014-09-17 アムジエン・インコーポレーテツド 生物活性を有する融合タンパク質を作製するための組成物及び方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633251B2 (en) * 1988-02-03 1993-01-28 Xoma Corporation Therapeutic use of anti-t cell immunotoxin for autoimmune diseases
EP0407399A4 (en) * 1988-02-03 1991-06-19 Xoma Corporation Immunosupression with anti-pan t-cell immunotoxin compositions

Also Published As

Publication number Publication date
PT98468A (pt) 1992-05-29
US5827655A (en) 1998-10-27
PT98468B (pt) 1998-01-30
FI930178A (fi) 1993-01-15
AU652381B2 (en) 1994-08-25
IE912645A1 (en) 1992-01-29
AU8424391A (en) 1992-03-02
JPH06500017A (ja) 1994-01-06
FI930178A0 (fi) 1993-01-15
WO1992002634A1 (en) 1992-02-20
EP0541704A1 (en) 1993-05-19
CA2087268A1 (en) 1992-01-28
EP0541704A4 (en) 1995-10-18

Similar Documents

Publication Publication Date Title
EP0635590A3 (de) Doppelriemchen-Streckwerk.
EP0630658A3 (en) Hyterosalpingography and selective salpingography.
EP0650844A3 (en) Shuttle type printers and methods for its implementation.
EP0636879A3 (en) Biosensor and method for its production.
ZA919797B (en) Bicyclo-5,6-dihydro-7h-pyrrolo-1,20-imidazol-7-ols and 7-ones
GR950300032T1 (en) Method and device for breadmaking.
EP0622623A3 (en) Sampling device.
ZA963997B (en) Lubricants with molybdenum containing compositions and methods of using the same.
AU1859388A (en) Tool changing device with tool registration detection and self-cleaning, and method therefor
GR3025747T3 (en) Device for the culture of molluses, in particular of oysters.
EP0645907A3 (en) Method and device for channel selection.
IL98932A0 (en) Assay,kits and methods based on nk+channel expression
EP0618271A3 (en) Siloxane rubber composition.
GB2239218B (en) Luminescent drawing or sketching device.
EP0600195A3 (en) Rubber composition.
AU8489591A (en) Methods and reagents for identifying bacteria
EP0656391A3 (en) Rubber composition.
NO902786L (no) Krympeverktoey samt fremgangsmaate for bruk av dette.
EP0850402A4 (en) PRETREATMENT REAGENTS AND RELATED METHODS
EP0661687A3 (en) Tremolo device.
ZA93782B (en) Determination method.
EP0650677A3 (en) Carrying device.
EP0652256A3 (en) Composition of silicone rubber.
EP0634658A3 (en) Biochemical analyzer and incubator therefor.
EP0618547A3 (en) Dispenser.